Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Caredx Inc (CDNA)

Caredx Inc (CDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,148,840
  • Shares Outstanding, K 53,634
  • Annual Sales, $ 280,320 K
  • Annual Income, $ -190,280 K
  • EBIT $ -60 M
  • EBITDA $ -45 M
  • 60-Month Beta 1.84
  • Price/Sales 4.00
  • Price/Cash Flow N/A
  • Price/Book 4.04

Options Overview Details

View History
  • Implied Volatility 69.43% ( -18.11%)
  • Historical Volatility 47.70%
  • IV Percentile 8%
  • IV Rank 23.60%
  • IV High 163.55% on 02/20/24
  • IV Low 40.36% on 07/03/24
  • Put/Call Vol Ratio 0.05
  • Today's Volume 80
  • Volume Avg (30-Day) 53
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 1,275
  • Open Int (30-Day) 1,969

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.21
  • Number of Estimates 2
  • High Estimate -0.20
  • Low Estimate -0.22
  • Prior Year -2.21
  • Growth Rate Est. (year over year) +90.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.09 +6.72%
on 12/18/24
26.37 -18.70%
on 12/04/24
-3.67 (-14.63%)
since 11/26/24
3-Month
20.09 +6.72%
on 12/18/24
32.97 -34.97%
on 10/02/24
-8.37 (-28.08%)
since 09/26/24
52-Week
7.42 +188.95%
on 04/26/24
34.84 -38.46%
on 08/19/24
+9.11 (+73.88%)
since 12/26/23

Most Recent Stories

More News
Here's Why You Should Add Ensign Group Stock to Your Portfolio Now

The Ensign Group, Inc. ENSG is benefiting from strategic acquisitions, an expanding footprint, rising service revenues and a strong financial position. An optimistic 2024 business outlook also reinforces...

VCYT : 40.95 (-0.56%)
EMBC : 20.83 (+2.71%)
CDNA : 21.44 (+0.09%)
ENSG : 135.30 (+0.43%)
Lobbying Update: CAREDX just disclosed $18,000 of lobbying spending

CAREDX just disclosed $18,000 of lobbying, from Q1 of 2024, in a new Lobbying Disclosure Act filing.This included lobbying on issues like:"CMS Coverage Policy"You can find more data on corporate lobbying...

CDNA : 21.44 (+0.09%)
Molina Healthcare Expands Dual Eligible Services in Michigan, Idaho

Molina Healthcare, Inc. MOH recently announced that it has secured significant wins by expanding its services to dual-eligible populations in Michigan and Idaho. In Michigan, the Michigan Department of...

EHC : 94.34 (+0.18%)
MD : 13.66 (-0.36%)
CDNA : 21.44 (+0.09%)
Ensign Group Rewards Shareholders With 4.2% Dividend Hike

The Ensign Group, Inc.'s ENSG board of directors recently approved a 4.2% hike in its quarterly cash dividend to boost shareholders' value. The increased dividend is 6.25 cents per share compared with...

EHC : 94.34 (+0.18%)
MD : 13.66 (-0.36%)
CDNA : 21.44 (+0.09%)
ENSG : 135.30 (+0.43%)
Insider Sale: Director at $CDNA (CDNA) Sells 5,000 Shares

Peter Maag, a director at $CDNA ($CDNA), sold 5,000 shares of the company on 11-26-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.5% of their shares. Following...

CDNA : 21.44 (+0.09%)
CareDx: Q3 Earnings Snapshot

CareDx: Q3 Earnings Snapshot

CDNA : 21.44 (+0.09%)
CareDx: Q2 Earnings Snapshot

CareDx: Q2 Earnings Snapshot

CDNA : 21.44 (+0.09%)
CareDx: Q1 Earnings Snapshot

CareDx: Q1 Earnings Snapshot

CDNA : 21.44 (+0.09%)
CareDx: Q4 Earnings Snapshot

CareDx: Q4 Earnings Snapshot

CDNA : 21.44 (+0.09%)
CareDx: Q3 Earnings Snapshot

CareDx: Q3 Earnings Snapshot

CDNA : 21.44 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

3rd Resistance Point 22.77
2nd Resistance Point 22.23
1st Resistance Point 21.83
Last Price 21.44
1st Support Level 20.89
2nd Support Level 20.35
3rd Support Level 19.95

See More

52-Week High 34.84
Fibonacci 61.8% 24.37
Last Price 21.44
Fibonacci 50% 21.13
Fibonacci 38.2% 17.89
52-Week Low 7.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar